Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Kristin A. Taskén"'
Autor:
Ingrid J. Guldvik, Verena Zuber, Peder R. Braadland, Helene H. Grytli, Håkon Ramberg, Wolfgang Lilleby, Bernd Thiede, Manuela Zucknick, Fahri Saatcioglu, Randi Gislefoss, Rune Kvåle, Anne George, Henrik Grönberg, Fredrik Wiklund, David E. Neal, Vincent J. Gnanapragasam, Kristin A. Taskén, Ian G. Mills
Publikováno v:
European Urology Open Science, Vol 21, Iss , Pp 51-60 (2020)
Background: More accurate risk assessments are needed to improve prostate cancer management. Objective: To identify blood-based protein biomarkers that provided prognostic information for risk stratification. Design, setting, and participants: Mass s
Externí odkaz:
https://doaj.org/article/19c31c60a395437dadf1c9b996dc004b
Autor:
Janna Berg, Ann Rita Halvorsen, May-Bente Bengtson, Kristin A. Taskén, Gunhild M. Mælandsmo, Arne Yndestad, Bente Halvorsen, Odd Terje Brustugun, Pål Aukrust, Thor Ueland, Åslaug Helland
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background The development of both chronic obstructive pulmonary disease (COPD) and lung cancer (LC) is influenced by smoking related chronic pulmonary inflammation caused by an excessive innate immune response to smoke exposure. In addition
Externí odkaz:
https://doaj.org/article/a84cb4acb5734bbb94566c7268ae77e2
Autor:
Ingrid Jenny Guldvik, Peder Rustøen Braadland, Shivanthe Sivanesan, Håkon Ramberg, Gitte Kristensen, Pierre Tennstedt, Andreas Røder, Thorsten Schlomm, Viktor Berge, Lars Magne Eri, Wolfgang Lilleby, Ian G. Mills, Kristin Austlid Taskén
Publikováno v:
European Urology Open Science, Vol 45, Iss , Pp 68-75 (2022)
Background: After radical prostatectomy (RP), depending on stage, up to 40% of patients with prostate cancer (PCa) will experience biochemical failure (BF). Despite salvage therapy, approximately one-third of these patients will need permanent hormon
Externí odkaz:
https://doaj.org/article/4bb9e8665eca453fb6a2b5e1d3055677
Autor:
Kristin Austlid Taskén, Anders Bjartell, Ian G. Mills, Aud Svindland, Wanzhong Wang, Kirsi Ketola, Andreas Engedal, Ingrid Jenny Guldvik, Heidi Kristin Nielsen, Alfonso Urbanucci, Helene Hartvedt Grytli, Håkon Ramberg, Peder R. Braadland
Therapy resistance shADRB2 cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467abd00f8362caf94794d0190f5b47f
https://doi.org/10.1158/1541-7786.22512538
https://doi.org/10.1158/1541-7786.22512538
Autor:
Kristin Austlid Taskén, Anders Bjartell, Ian G. Mills, Aud Svindland, Wanzhong Wang, Kirsi Ketola, Andreas Engedal, Ingrid Jenny Guldvik, Heidi Kristin Nielsen, Alfonso Urbanucci, Helene Hartvedt Grytli, Håkon Ramberg, Peder R. Braadland
Canonical WNT signalling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bfe3ef363d9672390f415a9934085a0
https://doi.org/10.1158/1541-7786.22512532.v1
https://doi.org/10.1158/1541-7786.22512532.v1
Autor:
Kristin Austlid Taskén, Anders Bjartell, Ian G. Mills, Aud Svindland, Wanzhong Wang, Kirsi Ketola, Andreas Engedal, Ingrid Jenny Guldvik, Heidi Kristin Nielsen, Alfonso Urbanucci, Helene Hartvedt Grytli, Håkon Ramberg, Peder R. Braadland
The incidence of treatment-related neuroendocrine prostate cancer (t-NEPC) is rising as more potent drugs targeting the androgen signaling axis are clinically implemented. Neuroendocrine transdifferentiation (NEtD), an putative initial step in t-NEPC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd112327e511e64a9fce391ef1321a92
https://doi.org/10.1158/1541-7786.c.6540265.v1
https://doi.org/10.1158/1541-7786.c.6540265.v1
Autor:
Kristin Austlid Taskén, Anders Bjartell, Ian G. Mills, Aud Svindland, Wanzhong Wang, Kirsi Ketola, Andreas Engedal, Ingrid Jenny Guldvik, Heidi Kristin Nielsen, Alfonso Urbanucci, Helene Hartvedt Grytli, Håkon Ramberg, Peder R. Braadland
Publically available data sets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60cc7a8ddb54597f8a991d21f687b7fb
https://doi.org/10.1158/1541-7786.22512526.v1
https://doi.org/10.1158/1541-7786.22512526.v1
Autor:
Kristin Austlid Taskén, Anders Bjartell, Ian G. Mills, Aud Svindland, Wanzhong Wang, Kirsi Ketola, Andreas Engedal, Ingrid Jenny Guldvik, Heidi Kristin Nielsen, Alfonso Urbanucci, Helene Hartvedt Grytli, Håkon Ramberg, Peder R. Braadland
Cell growth 2D and 3D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d99fd6da7763ecae309f4310c56dea9
https://doi.org/10.1158/1541-7786.22512523
https://doi.org/10.1158/1541-7786.22512523
Autor:
Kristin Austlid Taskén, Anders Bjartell, Ian G. Mills, Aud Svindland, Wanzhong Wang, Kirsi Ketola, Andreas Engedal, Ingrid Jenny Guldvik, Heidi Kristin Nielsen, Alfonso Urbanucci, Helene Hartvedt Grytli, Håkon Ramberg, Peder R. Braadland
Supplementary Material and Methods, Supplementary Figure Legends, Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511fe4e6a1213a9fbfeb892b46ae16a6
https://doi.org/10.1158/1541-7786.22512550
https://doi.org/10.1158/1541-7786.22512550
Autor:
Caroline E. Nunes-Xavier, Maite Emaldi, Ingrid J. Guldvik, Håkon Ramberg, Kristin A. Taskén, Gunhild M. Mælandsmo, Øystein Fodstad, Roberto Llarena, Rafael Pulido, José I. López
Publikováno v:
Pathology, research and practice. 241
Prostate cancer diagnosis and early stratification is an important aspect to avoid undertreatment of high-risk prostate cancer patients. Major Vault Protein (MVP) has been proposed as a prognostic biomarker in prostate cancer. PTEN and the immune che